celastrol has been researched along with Cancer of Skin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmad, F; Al-Tamimi, M; Alam, M; Anver, R; Buddenkotte, J; Khan, AQ; M Mateo, J; Raza, SS; Steinhoff, M; Uddin, S | 1 |
| Chen, F; Hou, L; Huang, L; Liu, Q; Shen, L; Wang, D; Zhang, X | 1 |
| Abbas, S; Bhoumik, A; Cosford, ND; Dahl, R; Krajewski, S; Ronai, ZA; Vasile, S | 1 |
3 other study(ies) available for celastrol and Cancer of Skin
| Article | Year |
|---|---|
Pristimerin mediated anticancer effects and sensitization of human skin cancer cells through modulation of MAPK signaling pathways.
Topics: Carcinoma, Squamous Cell; Humans; MAP Kinase Signaling System; Reactive Oxygen Species; Skin Neoplasms | 2022 |
Nanocarrier-Mediated Chemo-Immunotherapy Arrested Cancer Progression and Induced Tumor Dormancy in Desmoplastic Melanoma.
Topics: Animals; Antineoplastic Agents; Cell Death; Cell Line, Tumor; Cell Proliferation; Disease Progression; Drug Carriers; Drug Delivery Systems; Drug Screening Assays, Antitumor; Immunosenescence; Immunotherapy; Melanoma; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitoxantrone; Nanoparticles; NIH 3T3 Cells; Pentacyclic Triterpenes; Skin Neoplasms; Triterpenes; Tumor Microenvironment | 2018 |
Preclinical studies of celastrol and acetyl isogambogic acid in melanoma.
Topics: Activating Transcription Factor 2; Animals; Cell Line, Tumor; Chromones; Drug Evaluation, Preclinical; Drug Screening Assays, Antitumor; Humans; MAP Kinase Kinase 4; Melanoma; Mice; Pentacyclic Triterpenes; Proto-Oncogene Proteins c-jun; Skin Neoplasms; Small Molecule Libraries; Transcription, Genetic; Triterpenes | 2007 |